Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 119
1984 222
1985 258
1986 303
1987 329
1988 279
1989 284
1990 306
1991 327
1992 309
1993 381
1994 415
1995 438
1996 448
1997 483
1998 581
1999 549
2000 600
2001 653
2002 744
2003 889
2004 827
2005 1461
2006 1009
2007 1097
2008 1294
2009 1293
2010 1239
2011 1208
2012 1083
2013 1081
2014 1012
2015 1019
2016 1079
2017 862
2018 718
2019 679
2020 656
2021 635
2022 803
2023 924
2024 751
2025 641
2026 335

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28,147 results

Results by year

Filters applied: . Clear all
Page 1
Erratum: VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.
Hurvitz SA, Layman RM, Curigliano G, André F, Cristofanilli M, Kim SB, Martínez Rodríguez JL, Nadal JC, Kim GM, Lo L, Remolina-Bonilla YA, Rosselli G, Emile G, Korbenfeld E, Puig JM, Wesolowski R, Martin M, Ring A, Han HS, Giordano A, Mutka SC, Moss K, Suzuki S, Sullivan B, Gorbatchevsky I, Pistilli B; VIKTORIA-1 Study Group. Hurvitz SA, et al. J Clin Oncol. 2026 Jun 4:JCO2601302. doi: 10.1200/JCO-26-01302. Online ahead of print. J Clin Oncol. 2026. PMID: 42241670 No abstract available.
Reducing or omitting dexamethasone with NEPA and olanzapine for prevention of chemotherapy-induced nausea and vomiting in highly emetogenic chemotherapy: a randomized non-inferiority phase III trial.
Meng Y, Liu Y, Lin M, Wang L, Mu Y, Yang L, Du Y, Liu X, Chen Y, Tian S, Zhou Q, Zhuang X, Li Z, Liu J, Fang S, Fan W, Mao Y, Zhang L, Wu H, Yan F, Weng J, Zhao J, Long X, Liu L, Zhou J, Zhang J. Meng Y, et al. J Clin Oncol. 2026 Jun 4:101200JCO2601029. doi: 10.1200/JCO-26-01029. Online ahead of print. J Clin Oncol. 2026. PMID: 42241642
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.
Doroshow DB, Leal TA, Waqar SN, Borghaei H, Camidge DR, Dragnev KH, Edelman MJ, Gandara DR, Gerber DE, Gray JE, Hirsch FR, Husain H, Kozono DE, Leighl NB, Li BT, Mack PC, Neal JW, Paik PK, Patel SP, Riess JW, Redman MW, Reckamp KL. Doroshow DB, et al. J Clin Oncol. 2026 Jun 3:JCO2501896. doi: 10.1200/JCO-25-01896. Online ahead of print. J Clin Oncol. 2026. PMID: 42234933 No abstract available.
Erratum: Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.
Scherpereel A, Baas P, Nowak AK, Tsao AS, Fujimoto N, Peters S, Mansfield AS, Popat S, Aragon YB, Talbot T, Grossi F, Kowalski D, Kaplan MA, Cardona AF, Soomro R, Hu N, Lee A, Ip V, Hung YH, Zalcman G. Scherpereel A, et al. J Clin Oncol. 2026 Jun 2:JCO2601289. doi: 10.1200/JCO-26-01289. Online ahead of print. J Clin Oncol. 2026. PMID: 42228897 No abstract available.
28,147 results
You have reached the last available page of results. Please see the User Guide for more information.